Log out

Copyright © 2020 InvestorPlace Media, LLC. All rights reserved. 1125 N. Charles St, Baltimore, MD 21201.

Turning Point Brands (TPB)

$31.56 1.15 (3.50%)

12:50 EDT TPB Stock Quote Delayed 30 Minutes

Volume:

Previous Close $32.71

Market Cap 607.24M

PE Ratio 28.96

EPS 1.09

Volume (Avg. Vol.) 33,853

Day's Range 31.37 - 32.51

52-Week Range 14.09 - 40.46

Dividend & Yield 0.16 (0.51%)

TPB Stock Predictions, Articles, and Turning Point Brands News

From InvestorPlace
From the Web

9 Smaller Marijuana Stocks You Shouldn’t Ignore

By Josh Enomoto, InvestorPlace Contributor Jul 22, 2020

Smaller and speculative marijuana stocks took a beating following the initial coronavirus strike. However, they could also generate massive profitability for the risk-tolerant speculator.

5 Vaping Stocks That Won’t Fold Under Federal Regulation

By Alex Sirois Jul 17, 2020

Vaping stocks have the potential to explode following recent controversy. Click for the companies best positioned to come out on top.

9 Quirky Stocks to Buy for the ‘New Normal’

By Josh Enomoto, InvestorPlace Contributor Apr 29, 2020

Although the novel coronavirus has disrupted every aspect of our lives, these nine quirky stocks to buy may be weird enough to jump higher.

4 Vaping Stocks to Consider Buying Now

By Ian Bezek, InvestorPlace Contributor Jan 10, 2020

Investors are dumping their vaping stocks as public outcry and regulatory risk are mounting. However, this selloff created some solid buys.

7 Vaping Stocks to Get into Ahead of the Crowd

By Josh Enomoto, InvestorPlace Contributor Dec 19, 2019

One of the negative headlines that riveted the nation was the vaping crisis. However, a deeper look into the details suggests that contrarians have upside opportunities with vaping stocks to buy.

4 Stocks to Sell and 6 Stocks to Buy on Vaping Fears

By James Brumley, InvestorPlace Feature Writer Sep 26, 2019

Turning Point Brands, Cronos Group and Altria are just some of the stocks to buy or sell here at a pivotal time for vaporizers.

Compare Brokers

5 Small-Cap Stocks With Solid Earnings and From Winning Sectors

By Zacks Investment Research May 21, 2018

Small-cap earnings came in upbeat in Q1. Play the winning sectors with these top-ranked stocks. Compare Brokers....

athenahealth, Inc (ATHN), Yelp Inc (YELP) Leads Today’s Top 30 Investor Filings

By Fintel Jun 13, 2017

13D and 13G filings are windows into activist investor activity. Today's focus in on athenahealth, Inc. and Yelp among 30 new filings

Finish Line Inc (FINL) and Puma Biotech Inc (PBYI) Lead 15 Notable Investor Filings

By Fintel Jun 6, 2017

13D and 13G filings are windows into activist investor activity. We focus on Finish Line and 14 other filings of note

The Daily Biotech Pulse: Bristol-Myers, Bluebird Bio Resubmit Multiple Myeloma Drug BLA, FSD To Close Medicinal Cannabis Business, Hologic's Blowout Quarter

From Benzinga Jul 30, 2020

Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 29) Abbott Laboratories (NYSE: ABT) ABIOMED, Inc. (NASDAQ: ABMD) Adamis Pharmaceuticals Corp (NASDAQ: ADMP) Annexon...

4 Stocks to Keep an Eye on as Analysts Initiate Coverage

From Zacks Investment Research Jul 3, 2020

Increased analyst coverage over the last few weeks might lead to solid price appreciation for these stocks.

The Daily Biotech Pulse: Verrica Flags Potential Regulatory Delay, Back-To-Back FDA Approvals For Merck's Keytruda, OncoCyte Stalls Lung Nodule Malignancy Test

From Benzinga Jun 30, 2020

The following is a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 29) ADC Therapeutics SA (...

74 Biggest Movers From Yesterday

From Benzinga Jun 30, 2020

Gainers BioHiTech Global, Inc. (NASDAQ: BHTG) shares jumped 66.1% to close at $2.74 on Monday amid chatter the company's aerosol product can kill coronavirus. PDS...

Imara's IMR-687 an Orphan Drug in U.S. for beta-thalassemia (NASDAQ:IMRA)

From Seeking Alpha Jun 24, 2020

The FDA has granted Orphan Drug Designation for IMARA's (NASDAQ:IMRA) IMR-687 for the treatment of patients with beta-thalassemia.Among the benefits of Orphan Drug status in the U.S. is a seven-year

The Daily Biotech Pulse: MediciNova On Track For European Patent Win, Partial Clinical Hold Lifted For Innate Pharma, Tela Bio Details Coronavirus Impact

From Benzinga Jun 24, 2020

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 23) ACADIA Pharmaceuticals Inc...

Navellier Ratings

Powered by Portfolio Grader

Total Grade

C

Hold